Literature DB >> 16643196

A new instrument for measuring self-efficacy in patients with an anterior cruciate ligament injury.

P Thomeé1, P Währborg, M Börjesson, R Thomeé, B I Eriksson, J Karlsson.   

Abstract

It has been suggested that self-efficacy belief is of major importance for rehabilitation outcome after sports-related injuries. No instruments are, however, available to evaluate perceived self-efficacy for prognostic and outcome expectations in patients with an anterior cruciate ligament (ACL) injury. Perceived self-efficacy is defined as a judgment of one's potential ability to carry out a task, rather than a measure of whether or not one actually can or does perform the task. The purpose of this study was to develop a reliable and valid instrument for measuring perceived self-efficacy in patients with an ACL injury. A total of 210 male and female patients with an ACL injury were included in this study. The items were generated by health professionals with long clinical experience of patients with an ACL injury and by discussions with patients. After item analysis and item reduction, based on the results from 88 patients, the final 22-item version of the Knee Self-Efficacy Scale (K-SES) was evaluated in 18 patients for test-retest reliability and in 104 patients for internal consistency and validity. The K-SES was compared with the Multidimensional Health Locus of Control (MHLC), Coping Strategies Questionnaire (CSQ), SF-36 and Knee Injury and Osteoarthritis Outcome Score (KOOS) instruments. A factor analysis was also performed on the K-SES. The test-retest revealed a correlation of r(s)=0.73 between test-days and an intraclass correlation coefficient of 0.75. No significant difference between test-days was found. The internal consistency was 0.94, as calculated with Cronbach's alpha. There were low correlations between the K-SES and MHLC and the K-SES and CSQ, respectively. A strong correlation was found between the K-SES and physical functioning, as measured by the SF-36 (r(s)=0.8). All the sub-scales in the KOOS correlated moderately to strongly (r(s)=0.4-0.7) to the K-SES. The factor analysis produced two factors of importance. Factor one was related to how patients perceived their present physical performance/function, while factor two was related to how patients perceived the future physical performance/prognosis of their knee. Good reliability and good face, content, construct and convergent validity were demonstrated for this new instrument (K-SES) for measuring perceived self-efficacy in patients with an ACL injury. The K-SES is recommended for studies designed to evaluate prognostic and outcome expectations of perceived self-efficacy in patients with an ACL-insufficient knee.

Entities:  

Mesh:

Year:  2006        PMID: 16643196     DOI: 10.1111/j.1600-0838.2005.00472.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  46 in total

1.  A new hamstring test to complement the common clinical examination before return to sport after injury.

Authors:  C M Askling; J Nilsson; A Thorstensson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-09-18       Impact factor: 4.342

2.  Variability in leg muscle power and hop performance after anterior cruciate ligament reconstruction.

Authors:  Roland Thomeé; Camille Neeter; Alexander Gustavsson; Pia Thomeé; Jesper Augustsson; Bengt Eriksson; Jon Karlsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-02-08       Impact factor: 4.342

Review 3.  Psychological predictors of anterior cruciate ligament reconstruction outcomes: a systematic review.

Authors:  Joshua S Everhart; Thomas M Best; David C Flanigan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-15       Impact factor: 4.342

4.  Measurements of self-efficacy in musculoskeletal rehabilitation: A systematic review.

Authors:  Kelsey J Picha; Kate N Jochimsen; Nicholas R Heebner; John P Abt; Ellen L Usher; Gilson Capilouto; Tim L Uhl
Journal:  Musculoskeletal Care       Date:  2018-09-20

5.  Longitudinal changes in psychosocial factors and their association with knee pain and function after anterior cruciate ligament reconstruction.

Authors:  Terese L Chmielewski; Giorgio Zeppieri; Trevor A Lentz; Susan M Tillman; Michael W Moser; Peter A Indelicato; Steven Z George
Journal:  Phys Ther       Date:  2011-06-23

Review 6.  Optimization of the Return-to-Sport Paradigm After Anterior Cruciate Ligament Reconstruction: A Critical Step Back to Move Forward.

Authors:  Bart Dingenen; Alli Gokeler
Journal:  Sports Med       Date:  2017-08       Impact factor: 11.136

7.  Psychological factors are associated with return to pre-injury levels of sport and physical activity after ACL reconstruction.

Authors:  Shelby E Baez; Matthew C Hoch; Johanna M Hoch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-09-05       Impact factor: 4.342

8.  A novel patient-reported outcome measure for anterior cruciate ligament injury: evaluating the reliability, validity, and responsiveness of Japanese anterior cruciate ligament questionnaire 25.

Authors:  Masashi Nagao; Tokuhide Doi; Yoshitomo Saita; Yohei Kobayashi; Mitsuaki Kubota; Haruka Kaneko; Yuji Takazawa; Muneaki Ishijima; Hisashi Kurosawa; Kazuo Kaneko; Masahiko Nozawa; Hiroshi Ikeda; Sung-Gon Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-04-17       Impact factor: 4.342

9.  General health and knee function outcomes from 7 days to 12 weeks after spinal anesthesia and multimodal analgesia for anterior cruciate ligament reconstruction.

Authors:  Brian A Williams; Qainyu Dang; James E Bost; James J Irrgang; Steven L Orebaugh; Matthew T Bottegal; Michael L Kentor
Journal:  Anesth Analg       Date:  2009-04       Impact factor: 5.108

10.  Relationships between postural orientation and self reported function, hop performance and muscle power in subjects with anterior cruciate ligament injury.

Authors:  Anna Trulsson; Ewa M Roos; Eva Ageberg; Martin Garwicz
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.